Researchers: Gene therapy may offer cure for sickle cell disease

Researchers have developed a gene therapy for sickle cell anemia that allowed laboratory animals and human tissue samples to produce normal red blood cells instead of the misshapen ones that are the hallmark of the disease. The therapy involves implanting a gene that neutralizes the function of hemoglobin S, which is responsible for the malformed blood cells. The researchers plan to test the treatment on humans next year, pending regulatory approval.

View Full Article in:

Cincinnati Enquirer, The (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ